Formulation and Development of Metformin-Loaded Microspheres Using Eudragit S-100 as a Carrier Polymer
Oriental Journal Of Chemistry · 26.06.2026 · 3 (42) · 997
DOI: 10.13005/ojc/420318 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oriental Journal Of Chemistry, online erschienen am 25.06.2026. Verfasst von Pawan Singh und 4 weiteren Autor:innen. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Metformin hydrochloride (MH), a member of the biguanide class of oral antidiabetic agents, is extensively used in the management of DM type II. Nonetheless, its therapeutic potential is limited because of its short half-life and relatively low oral absorption (approx. 55-60%), requiring multiple dosing. The purpose of the current study was to formulate and evaluate sustained release microspheres of Metformin hydrochloride by the solvent evaporation method to improve its bioavailability and effective duration of action. Microspheres were developed by the technique of solvent evaporation employing Eudragit S100 and Sodium CMC as polymeric carriers. After optimising polymer amounts, thirteen formulations (F1–F13) were prepared. The formulations were assessed based on % yield, % drug EE, surface morphology, scanning electron microscopy (SEM), FTIR pattern and in vitro drug release studies. There was no pronounced interaction between the drug and polymers, as observed from the FTIR spectra. SEM observation indicated that the higher the concentration of polymer, the smoother the microsphere surface. F6 was best among the formulations with a production yield of 96.78±0.005%, drug entrapment efficiency of 80.72±0.020%, and sustained drug release of 96.52±0.010%. Card Sort F6 Card Sort revealed that all formulations showed an efficient encapsulation and an economically controlled release profile; however, the F6 formulation was selected as the most optimised formulation. The optimised Metformin hydrochloride sustained release formulations E8, F6 and G3 were acceptable in terms of physicochemical properties andin vitro drug release pattern, out of which formulation F6 was considered as an ideal sustained-release delivery system of Metformin hydrochloride. The present plan of work demonstrates the feasibility of the solvent evaporation method for the preparation of controlled release microspheres to improve the bioavailability and lower the dosing frequency of anti-diabetic therapy.
Zitieren
APA
Singh, P., Shrivastav, A., Sharma, V., Junaid, M., & Khan, M. (2026). Formulation and Development of Metformin-Loaded Microspheres Using Eudragit S-100 as a Carrier Polymer. Oriental Journal Of Chemistry, 3(42), 997. https://doi.org/10.13005/ojc/420318
Vancouver
Singh P, Shrivastav A, Sharma V, Junaid M, Khan M. Formulation and Development of Metformin-Loaded Microspheres Using Eudragit S-100 as a Carrier Polymer. Oriental Journal Of Chemistry. 2026;3(42):997. doi:10.13005/ojc/420318
BibTeX
@article{Singh2026,
author = {Singh, Pawan and Shrivastav, Alankar and Sharma, Vijay and Junaid, Mohd and Khan, Mariyam},
title = {Formulation and Development of Metformin-Loaded Microspheres Using Eudragit S-100 as a Carrier Polymer},
journal = {Oriental Journal Of Chemistry},
year = {2026},
volume = {3},
number = {42},
pages = {997},
doi = {10.13005/ojc/420318}
}
EUVIMED